Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $501,059 | 271 | 71.0% |
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | $72,000 | 26 | 10.2% |
| Travel and Lodging | $65,580 | 589 | 9.3% |
| Food and Beverage | $39,757 | 829 | 5.6% |
| Consulting Fee | $16,650 | 7 | 2.4% |
| Compensation for serving as faculty or as a speaker for a medical education program | $9,975 | 3 | 1.4% |
| Honoraria | $320.00 | 1 | 0.0% |
| Education | $214.47 | 4 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Allergan, Inc. | $194,983 | 564 | $0 (2020) |
| NESTLE HEALTHCARE NUTRITION INC. | $177,485 | 318 | $0 (2023) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $125,124 | 247 | $0 (2023) |
| AIMMUNE THERAPEUTICS, INC. | $90,215 | 106 | $0 (2024) |
| ABBVIE INC. | $64,134 | 127 | $0 (2024) |
| Phathom Pharmaceuticals, Inc. | $30,621 | 55 | $0 (2024) |
| Valeant Pharmaceuticals North America LLC | $8,779 | 24 | $0 (2017) |
| Bausch Health US, LLC | $3,594 | 5 | $0 (2018) |
| Ironwood Pharmaceuticals, Inc | $1,589 | 50 | $0 (2021) |
| Boston Scientific Corporation | $1,446 | 24 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $140,133 | 232 | AIMMUNE THERAPEUTICS, INC. ($90,215) |
| 2023 | $60,258 | 149 | NESTLE HEALTHCARE NUTRITION INC. ($47,018) |
| 2022 | $57,375 | 130 | Nestle HealthCare Nutrition Inc. ($29,132) |
| 2021 | $127,990 | 221 | Nestle HealthCare Nutrition Inc. ($87,067) |
| 2020 | $32,677 | 101 | Nestle HealthCare Nutrition Inc. ($14,267) |
| 2019 | $102,381 | 297 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($58,335) |
| 2018 | $133,157 | 409 | Allergan Inc. ($102,455) |
| 2017 | $51,584 | 191 | Allergan Inc. ($41,308) |
All Payment Transactions
1,730 individual payment records from CMS Open Payments — Page 1 of 70
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $23.26 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/19/2024 | ABBVIE INC. | CREON (Drug) | Food and Beverage | In-kind items and services | $12.26 | General |
| Category: ENDOCRINOLOGY | ||||||
| 12/18/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,950.00 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 12/18/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,262.50 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 12/18/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,580.00 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/18/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,150.00 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/18/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,290.00 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/18/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Travel and Lodging | Cash or cash equivalent | $373.86 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 12/18/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Travel and Lodging | Cash or cash equivalent | $265.29 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 12/18/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Travel and Lodging | Cash or cash equivalent | $226.36 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/18/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Travel and Lodging | Cash or cash equivalent | $170.18 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 12/18/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Travel and Lodging | Cash or cash equivalent | $154.36 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 12/18/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Travel and Lodging | Cash or cash equivalent | $130.15 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/18/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | Cash or cash equivalent | $31.50 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 12/18/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | Cash or cash equivalent | $27.73 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 12/18/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | Cash or cash equivalent | $22.04 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 12/18/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Travel and Lodging | Cash or cash equivalent | $20.00 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 12/18/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Travel and Lodging | Cash or cash equivalent | $20.00 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 12/18/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | Cash or cash equivalent | $17.12 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 12/18/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | Cash or cash equivalent | $8.48 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 12/17/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $13.87 | General |
| Category: IMMUNOLOGY | ||||||
| 12/11/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,150.00 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/11/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/10/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $124.95 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/09/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $16.98 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 706 | 1,075 | $295,170 | $104,740 |
| 2022 | 10 | 838 | 1,398 | $368,090 | $129,925 |
| 2021 | 13 | 892 | 1,334 | $360,550 | $134,051 |
| 2020 | 13 | 880 | 1,810 | $375,540 | $148,791 |
All Medicare Procedures & Services
54 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 142 | 487 | $58,440 | $32,022 | 54.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 115 | 115 | $29,900 | $14,904 | 49.8% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 64 | 64 | $56,320 | $14,788 | 26.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 124 | 139 | $25,500 | $14,275 | 56.0% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 88 | 90 | $50,400 | $7,608 | 15.1% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 40 | 40 | $30,800 | $5,784 | 18.8% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 29 | 30 | $6,600 | $3,318 | 50.3% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 29 | 30 | $5,480 | $2,994 | 54.6% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 14 | 14 | $9,760 | $2,744 | 28.1% |
| 43246 | Insertion of stomach tube using a flexible endoscope | Facility | 2023 | 13 | 13 | $5,980 | $2,329 | 39.0% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2023 | 14 | 14 | $8,960 | $1,810 | 20.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 16 | 21 | $2,520 | $1,329 | 52.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 18 | 18 | $4,510 | $836.16 | 18.5% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 193 | 705 | $84,600 | $42,064 | 49.7% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 99 | 101 | $88,880 | $23,201 | 26.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 129 | 164 | $29,520 | $16,032 | 54.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 107 | 107 | $27,820 | $13,867 | 49.8% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 81 | 86 | $18,920 | $9,905 | 52.4% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 94 | 96 | $53,760 | $8,331 | 15.5% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 39 | 39 | $30,030 | $5,511 | 18.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 42 | 42 | $10,500 | $3,278 | 31.2% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2022 | 14 | 14 | $9,675 | $2,930 | 30.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 16 | 16 | $4,160 | $1,810 | 43.5% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2022 | 11 | 11 | $7,085 | $1,738 | 24.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 13 | 17 | $3,140 | $1,256 | 40.0% |
About Dr. Arin Newman, MD
Dr. Arin Newman, MD is a Internal Medicine healthcare provider based in Miami Beach, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/23/2005. The National Provider Identifier (NPI) number assigned to this provider is 1447256540.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Arin Newman, MD has received a total of $705,556 in payments from pharmaceutical and medical device companies, with $140,133 received in 2024. These payments were reported across 1,730 transactions from 56 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($501,059).
As a Medicare-enrolled provider, Newman has provided services to 3,316 Medicare beneficiaries, totaling 5,617 services with total Medicare billing of $517,506. Data is available for 4 years (2020–2023), covering 54 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Other Specialties Gastroenterology
- Location Miami Beach, FL
- Active Since 06/23/2005
- Last Updated 06/18/2010
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1447256540
Products in Payments
- ZENPEP (Drug) $358,844
- LINZESS (Drug) $121,175
- XIFAXAN (Drug) $68,549
- VOQUEZNA (Drug) $30,621
- PLENVU (Drug) $24,166
- CREON (Drug) $19,648
- RELISTOR (Drug) $15,285
- VIBERZI (Drug) $14,564
- TRULANCE (Drug) $12,967
- DOPTELET (Drug) $11,683
- UCERIS (Drug) $2,305
- APRISO (Drug) $2,270
- OCALIVA (Drug) $933.44
- STELARA (Biological) $843.52
- RINVOQ (Biological) $721.70
- Linzess (Drug) $608.38
- Humira (Biological) $565.06
- ZEPOSIA (Drug) $516.92
- TREMFYA (Drug) $493.54
- Kerendia (Drug) $413.82
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Miami Beach
Cynthia Rivera, M.d, M.D
Internal Medicine — Payments: $281,189
Dr. Simon Blanc, M.d, M.D
Internal Medicine — Payments: $119,116
Dr. Jason Shapiro, Md, MD
Internal Medicine — Payments: $69,524
Dr. Michael Wohlfeiler, Md, MD
Internal Medicine — Payments: $66,464
Dr. Christos Mihos, D.o, D.O
Internal Medicine — Payments: $61,438
Alex Manzano, M.d, M.D
Internal Medicine — Payments: $57,933